30
/ru/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
2162554
179119
2
Public Timelines FAQ
Public TimelinesFAQ
Public TimelinesFAQ
For educational institutions For teachers For students Open cabinet
For educational institutions For teachers For students Open cabinet
Создать
Create a timeline
Public timelines
Library
FAQ

1 янв 2016 г. - Pembrolizumab extends NSCLC survival, with fewer side effects

Описание:

Pembrolizumab improves survival and causes fewer side effects than standard chemotherapy for patients.

Добавлено на ленту времени:

Cancer Dates

ByLakayla
16 ноя 2018

Дата:

1 янв 2016 г.
Сейчас
~ 8 гг и 4 мес назад
About & FeedbackСоглашениеПриватностьБиблиотека
2024 © Time.Graphics
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Excellent (Trustpilot Reviews)
Based on 115+ reviews
Write your own review on Trustpilot.com